Nanohealth

Nanotechnology Committee of Iran Food and Drug Administration (IFDA) has been formed to develop guidelines to assess and approve Nano-Health products of Iran's Market in the areas of pharmaceuticals, medical equipment, cosmetics and hygienic, food, beverages and pharmaceutical supplements.   Committee members include committee chairman and secretary in general, director of different departments in the Iran Food and Drug Administration (IFDA) and assignee of Iran Nanotechnology Initiative Council (INIC).    Committee activities are as follows:   1 - Developing guidelines and administrative instructions relating to assess and approve Nano-Health products 2 – Assessing and making decisions about the registered products. 3 - Educating experts of the Food and Drug Organization, Ministry of Health, the applicant companies, academic volunteers etc. 4 - Professional Promotion and interaction with manufacturers in the related areas 5 - Supporting the commercialization of Nano-Health products